[HTML][HTML] Management of Failing Kidney and Pancreas Transplantations
M Lubetzky, K Chauhan, L Alrata, C Dubrawka… - Advances in Kidney …, 2024 - Elsevier
Survival rates for allografts have improved over the last 2 decades, yet failing allografts
remains a challenge in the field of transplant. The risks of mortality and morbidity associated …
remains a challenge in the field of transplant. The risks of mortality and morbidity associated …
Predicting acute rejection in simultaneous pancreas-kidney transplantation using donor-derived cell-free DNA as biomarker
L Liu, G Li, P Zhang, R Chen, A Ouzaouit, T Jiang… - 2024 - researchsquare.com
Background: Donor-derived cell-free DNA (dd-cfDNA) has been evaluated as a rejection
marker in organ transplantation. Here, we assessed the predictive and diagnostic utility of dd …
marker in organ transplantation. Here, we assessed the predictive and diagnostic utility of dd …
Medical and Surgical Management of the Failed Pancreas Transplant: Erratum
KL Lentine, RF Parsons, T Alhamad - 2024 - journals.lww.com
Medical and Surgical Management of the Failed Pancreas Trans... : Transplantation Direct
Medical and Surgical Management of the Failed Pancreas Transplant: Erratum : Transplantation …
Medical and Surgical Management of the Failed Pancreas Transplant: Erratum : Transplantation …
[HTML][HTML] Luhao Liu 1 Guanghui Li 1 Peng Zhang 1 Rongxin Chen 1 A
A Ouzaouit, T Jiang, Y Guo, J Fang, J Ma - assets-eu.researchsquare.com
Background: Donor-derived cell-free DNA (dd-cfDNA) has been evaluated as a rejection
marker in organ transplantation. Here, we assessed the predictive and diagnostic utility of dd …
marker in organ transplantation. Here, we assessed the predictive and diagnostic utility of dd …